Aoxing Pharmaceutical (AOXG) 10-Q/A 2017 Q2 Quarterly report (amended)

Exhibit 32.1

CERTIFICATION

OF

CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. §1350

In connection with the quarterly report on Form 10-Q/A (Amendment No. 1)  (the "report") of Aoxing Pharmaceutical Company, Inc. (the "Company") for the fiscal period ended December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof the report, I, Zhenjiang Yue, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period.

February 17, 2017	/s/ Zhenjiang Yue
	Zhenjiang Yue, Chief Executive Officer

A signed original of this written statement has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and Exchange Commission or its staff upon request.